Homepage
Author:
ASCENTAGE PHARMA GROUP INTERNATIONAL
Posted Date:
March 25, 2026
Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates
ASCENTAGE PHARMA GROUP INTERNATIONAL
March 25, 2026
Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026
ASCENTAGE PHARMA GROUP INTERNATIONAL
March 17, 2026
Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026
ASCENTAGE PHARMA GROUP INTERNATIONAL
March 11, 2026
Ascentage Pharma to Participate in Three Upcoming Investor Conferences
ASCENTAGE PHARMA GROUP INTERNATIONAL
February 23, 2026
Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
ASCENTAGE PHARMA GROUP INTERNATIONAL
February 9, 2026
Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288
ASCENTAGE PHARMA GROUP INTERNATIONAL
February 8, 2026
